Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis

scientific article

Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0169-6009(08)80033-5
P698PubMed publication ID8453319

P2093author name stringKok DJ
Papapoulos SE
P2860cites workThe hypercalciurias. Causes, parathyroid functions, and diagnostic criteriaQ34465118
The medical aspects of urolithiasis: an overview.Q38603689
Gestational hypercalciuria causes pathological urine calcium oxalate supersaturationsQ41330489
Modulation of calcium oxalate monohydrate crystallization kinetics in vitroQ41879161
Crystal agglomeration is a major element in calcium oxalate urinary stone formationQ44071761
Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro.Q50966224
The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980.Q52878498
Crystalluria in marathon runnersQ58275171
Nucleation and growth of brushite and calcium oxalate in urine of stone-formersQ67455130
The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy menQ68922192
Idiopathic hypercalciuriaQ69486094
Calcium oxalate precipitation in a flow system: an attempt to simulate the early stages of stone formation in the renal tubulesQ69520042
Excessive crystal agglomeration with low citrate excretion in recurrent stone-formersQ69880756
Long-term treatment of calcium nephrolithiasis with potassium citrateQ69897051
Transient hyperoxaluria after ingestion of chocolate as a high risk factor for calcium oxalate calculiQ69944514
Architecture of calcium oxalate monohydrate urinary calculiQ70052304
Calcium crystalluria in recurrent renal-stone formersQ70111592
Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinicQ70460156
Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasisQ71278209
The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitroQ72894084
Urine saturation with calcium salts in normal subjects and idiopathic calcium stone-formers estimated by an improved computer model systemQ93625361
P433issue1
P921main subjectcalcium oxalateQ412399
urolithiasisQ1585769
P304page(s)1-15
P577publication date1993-01-01
P1433published inBone and MineralQ27710009
P1476titlePhysicochemical considerations in the development and prevention of calcium oxalate urolithiasis
P478volume20